This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Selective imidazoline receptor antagonists

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

SIRAs are centrally-acting antihypertensive drugs which are thought to target the imidazoline I1 receptor in the cardiovascular control centre in the brainstem.

Monoxidine is the first in this class of drug. Although better tolerated than the older centrally acting antihypertensives such as clonidine, there is no longterm outcome data.

SIRAs should be used when other treatments have been tried and have failed.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.